H.R. 4752 · 119th Congress · House

Reducing Hereditary Cancer Act

Active· Introduced in House
Introduced
Jul 23, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Reducing Hereditary Cancer Act

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Action Timeline

2
  1. JUL 23, 2025House floor actions

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  2. JUL 23, 2025Library of Congress

    Introduced in House

Committees

2

Ways and Means Committee

hswm00

Referred: Jul 23, 2025

Active

Energy and Commerce Committee

hsif00

Referred: Jul 23, 2025

Active